Literature DB >> 20229096

Association of dietary AGEs with circulating AGEs, glycated LDL, IL-1α and MCP-1 levels in type 2 diabetic patients.

Pei-chun Chao1, Chien-ning Huang, Cheng-chin Hsu, Mei-chin Yin, Yu-ru Guo.   

Abstract

PURPOSE: The association of dietary advanced glycation endproducts (AGEs) intake with the oxidative and inflammatory status in type 2 diabetic patients was examined.
METHODS: Seventy-four healthy controls, 50 low AGEs intake and 68 high AGEs intake type 2 diabetic patients were requested to complete a 7-day dietary record. Blood levels of several oxidative and inflammatory biomarkers were determined.
RESULTS: Diabetic patients with high AGEs intake had significantly elevated plasma levels of AGEs, HbA1c, low-density lipoprotein (LDL), LDL-cholesterol and glycated LDL than low AGEs intake patients and controls (P < 0.05). These high AGEs intake patients also had significantly increased plasma levels of 8-isoprostane, interleukin (IL)-1α, tumor necrosis factor-α, monocyte chemoattractant protein (MCP)-1 and lower superoxide dismutase (SOD) activity than low AGEs intake patients (P < 0.05). Correlation coefficients of dietary AGEs versus plasma AGEs, HbA1c, 8-isoprostane, IL-1α and MCP-1 were >0.6; but the correlation coefficient of dietary AGEs versus plasma SOD activity was <-0.6.
CONCLUSION: Increasing dietary AGEs intake might enrich circulating AGE level and contribute to oxidative and inflammatory progression under diabetic condition. The circulating 8-isoprostane, IL-1α and MCP-1 levels and SOD activity might be appropriate biomarkers used to evaluate dietary AGEs-associated oxidative and inflammatory stress.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20229096     DOI: 10.1007/s00394-010-0101-3

Source DB:  PubMed          Journal:  Eur J Nutr        ISSN: 1436-6207            Impact factor:   5.614


  25 in total

1.  Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy.

Authors:  N Demircan; B G Safran; M Soylu; A A Ozcan; S Sizmaz
Journal:  Eye (Lond)       Date:  2005-11-11       Impact factor: 3.775

2.  Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy.

Authors:  Helen Vlassara; Weijing Cai; Jill Crandall; Teresia Goldberg; Robert Oberstein; Veronique Dardaine; Melpomeni Peppa; Elliot J Rayfield
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-12       Impact factor: 11.205

Review 3.  Advanced glycation endproducts--role in pathology of diabetic complications.

Authors:  Nessar Ahmed
Journal:  Diabetes Res Clin Pract       Date:  2005-01       Impact factor: 5.602

Review 4.  Hyperglycemia, lipoprotein glycation, and vascular disease.

Authors:  Arvindan Veiraiah
Journal:  Angiology       Date:  2005 Jul-Aug       Impact factor: 3.619

5.  Effects of low- and high-advanced glycation endproduct meals on macro- and microvascular endothelial function and oxidative stress in patients with type 2 diabetes mellitus.

Authors:  Monica Negrean; Alin Stirban; Bernd Stratmann; Thomas Gawlowski; Tina Horstmann; Christian Götting; Knut Kleesiek; Michaela Mueller-Roesel; Theodor Koschinsky; Jaime Uribarri; Helen Vlassara; Diethelm Tschoepe
Journal:  Am J Clin Nutr       Date:  2007-05       Impact factor: 7.045

Review 6.  Forty years of furosine - forty years of using Maillard reaction products as indicators of the nutritional quality of foods.

Authors:  Helmut F Erbersdobler; Veronika Somoza
Journal:  Mol Nutr Food Res       Date:  2007-04       Impact factor: 5.914

7.  Reliable determination of furosine in human serum and dialysate proteins by high-performance liquid chromatography.

Authors:  Y C Wu; V Monnier; M Friedlander
Journal:  J Chromatogr B Biomed Appl       Date:  1995-05-19

8.  Identification of pentosidine as a native structure for advanced glycation end products in beta-2-microglobulin-containing amyloid fibrils in patients with dialysis-related amyloidosis.

Authors:  T Miyata; S Taneda; R Kawai; Y Ueda; S Horiuchi; M Hara; K Maeda; V M Monnier
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

Review 9.  Diabetic dyslipidemia.

Authors:  R A Kreisberg
Journal:  Am J Cardiol       Date:  1998-12-17       Impact factor: 2.778

10.  Low-density lipoprotein is the major carrier of lipid hydroperoxides in plasma. Relevance to determination of total plasma lipid hydroperoxide concentrations.

Authors:  J Nourooz-Zadeh; J Tajaddini-Sarmadi; K L Ling; S P Wolff
Journal:  Biochem J       Date:  1996-02-01       Impact factor: 3.857

View more
  24 in total

Review 1.  Dietary Advanced Glycation End Products and Cardiometabolic Risk.

Authors:  Claudia Luévano-Contreras; Armando Gómez-Ojeda; Maciste Habacuc Macías-Cervantes; Ma Eugenia Garay-Sevilla
Journal:  Curr Diab Rep       Date:  2017-08       Impact factor: 4.810

2.  Effects of sevelamer on HbA1c, inflammation, and advanced glycation end products in diabetic kidney disease.

Authors:  Helen Vlassara; Jaime Uribarri; Weijing Cai; Susan Goodman; Renata Pyzik; James Post; Fabrizio Grosjean; Mark Woodward; Gary E Striker
Journal:  Clin J Am Soc Nephrol       Date:  2012-03-29       Impact factor: 8.237

Review 3.  AGEs, RAGE, and diabetic retinopathy.

Authors:  Hongliang Zong; Micheal Ward; Alan W Stitt
Journal:  Curr Diab Rep       Date:  2011-08       Impact factor: 4.810

4.  Houttuynia cordata aqueous extract attenuated glycative and oxidative stress in heart and kidney of diabetic mice.

Authors:  Cheng-Chin Hsu; Hui-Ting Yang; Jing-Jing Ho; Mei-Chin Yin; Jen-Ying Hsu
Journal:  Eur J Nutr       Date:  2015-07-22       Impact factor: 5.614

Review 5.  Advanced Glycation End Products (AGEs) and Chronic Kidney Disease: Does the Modern Diet AGE the Kidney?

Authors:  Amelia K Fotheringham; Linda A Gallo; Danielle J Borg; Josephine M Forbes
Journal:  Nutrients       Date:  2022-06-28       Impact factor: 6.706

6.  Chemokines in Prediabetes and Type 2 Diabetes: A Meta-Analysis.

Authors:  Xiongfeng Pan; Atipatsa C Kaminga; Shi Wu Wen; Aizhong Liu
Journal:  Front Immunol       Date:  2021-05-13       Impact factor: 7.561

7.  Impact of cyanidin-3-glucoside on glycated LDL-induced NADPH oxidase activation, mitochondrial dysfunction and cell viability in cultured vascular endothelial cells.

Authors:  Xueping Xie; Ruozhi Zhao; Garry X Shen
Journal:  Int J Mol Sci       Date:  2012-11-27       Impact factor: 5.923

8.  Dietary advanced glycation end products restriction diminishes inflammation markers and oxidative stress in patients with type 2 diabetes mellitus.

Authors:  Claudia Luévano-Contreras; Ma Eugenia Garay-Sevilla; Kazimierz Wrobel; Juan M Malacara; Katarzyna Wrobel
Journal:  J Clin Biochem Nutr       Date:  2012-12-06       Impact factor: 3.114

9.  Cytokinome profile of patients with type 2 diabetes and/or chronic hepatitis C infection.

Authors:  Susan Costantini; Francesca Capone; Eliana Guerriero; Raffaele Marfella; Angela Sorice; Patrizia Maio; Michele Di Stasio; Giuseppe Paolisso; Giuseppe Castello; Giovanni Colonna
Journal:  PLoS One       Date:  2012-06-20       Impact factor: 3.240

Review 10.  Advanced glycation end-products: modifiable environmental factors profoundly mediate insulin resistance.

Authors:  Mona S Ottum; Anahita M Mistry
Journal:  J Clin Biochem Nutr       Date:  2015-07-01       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.